on 14 Mar 2019
Last Applicant/ Owned by
Chiyoda-ku Tokyo 100-0005
JP
Serial Number
79071476 filed on 13th Mar 2009
Registration Number
4326258 registered on 30th Apr 2013
Correspondent Address
Howard N. Aronson
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Laboratory apparatus and instruments for use in performing assays of endotoxin and beta-glucan concentrations, namely, spectrophotometers, test tubes, reaction tubes, assay microplates, pipette tips, 96-well microplates, reagent reservoirs, transfer pipettes, sample containers; Laboratory apparatus and instruments for use in measuring absorbance and turbidity and interpreting the results, namely, Read More
Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins and beta-glucan; Reagents for scientific medical research and quality control testing use, namely, for use in determining the presence of analytes in or on water, pharmaceutical products, medical devices, dialysate, blood, blood components, body fluids, and tissues; Reagents for clinical or medical laboratory use, namely, glycobiological analysis reagents and diagnostic preparations and reagents for clinical or medical laboratory use
Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Submucosal injection materials for endoscopes used for the treatment of dissecting and resecting tumors and cancer, namely, submucosal injectable preparations for treatment of dissecting and resecting tumors and cancer; Pharmaceutical preparations for the treatment of disc hernia; Syringes sold filled with crosslinked or non-crosslinked hyaluronic acid based gel; Syringes sold filled with sodium hyaluronate solutions; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes
Laboratory apparatus and instruments for use in performing assays of endotoxin and beta-glucan concentrations, namely, spectrophotometers, test tubes, reaction tubes, assay microplates, pipette tips, 96-well microplates, reagent reservoirs, transfer pipettes, sample containers; Laboratory apparatus and instruments for use in measuring absorbance and turbidity and interpreting the results, namely, density meters, concentration meters; Laboratory apparatus and instruments for use in analyzing urine, namely, clinical laboratory analyzers for measuring, testing and analyzing urine; Laboratory apparatus and instruments, namely, chemical and biochemical analytical instruments in the nature of laboratory chemical reactors, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Electronic machines, apparatus and their parts, namely, clinical chemistry analyzers for laboratory use in the analysis of biological samples; Magnetic media with recorded programs, namely, pre-recorded magnetic media featuring computer programs used to control and collect data from optical readers, and to analyze data and generate reports for use in the field of endotoxin and beta-glucan analysis
No 79071476
No Service/Collective Mark
No 14850
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
04th Oct 2019 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
04th Oct 2019 | DEATH OF INTERNATIONAL REGISTRATION |
30th Apr 2018 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
15th Aug 2014 | NEW REPRESENTATIVE AT IB RECEIVED |
24th Jan 2014 | FINAL DECISION TRANSACTION PROCESSED BY IB |
09th Jan 2014 | FINAL DISPOSITION PROCESSED |
09th Jan 2014 | FINAL DISPOSITION NOTICE SENT TO IB |
30th Jul 2013 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
30th Apr 2013 | REGISTERED-PRINCIPAL REGISTER |
03rd Mar 2013 | NOTIFICATION PROCESSED BY IB |